Broadstone Net Lease, Inc. (NYSE: BNL) ("Broadstone," "BNL," the "Company," "we," "our," or "us"), today announced that its Board of Directors (the "Board") has appointed Richard Imperiale, President ...
Kentucky State University welcomed university representatives from Ethiopia to campus Tuesday to discuss possible ...
CEO John Casella said the company “finished the year strong” by growing revenue by about 20%. The company also upgraded a MRF ...
The CEO emphasized that 2024 was a strong year, with revenues, adjusted EBITDA, and adjusted free cash flow all growing over 20%. He highlighted the completion of eight acquisitions in 2024, ...
Royalty Pharma PLC (RPRX) has disclosed a new risk, in the Regulation category. The planned internalization of Royalty Pharma LLC by RP Holdings, ...
Q4 2024 Earnings Call Transcript February 11, 2025 Royalty Pharma plc misses on earnings expectations. Reported EPS is $0.3509 EPS, expectations were $0.99. Operator: Ladies and gentlemen, thank you ...
Royalty Pharma PLC (RPRX) reports robust growth in 2024 with a new $3 billion share repurchase plan and strategic portfolio expansions.
Pablo Legorreta, CEO, highlighted strong 2024 performance, with Portfolio Receipts reaching $2.8 billion, at the high end of guidance and representing 13% growth in Royalty Receipts. He noted this ...
Announcing a new publication for Acta Materia Medica journal. Estrogens have been reported to cause dysfunction in biliary transport systems, thereby inducing cholestasis. Multidrug ...
Overall, these findings illustrate that miR-128-3p inhibits PDZK1 expression, thereby inhibiting the membrane localization of MRP2 in EIC. Enhancing or restoring PDZK1 expression might therefore have ...
Announcing a new publication for Acta Materia Medica journal. Estrogens have been reported to cause dysfunction in biliary transport systems, thereby inducing cholestasis. Multidrug ...
AI agents today struggle with efficiently mastering multiple tasks due to their heavy reliance on prompts. The traditional ...